GRIGORYAN GEVORG enters GENERATE BIOMEDICINES, INC. with 659.97K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/26/2026ACC: 0001193125-26-078404
Officer· Chief Technology Officer
Since Feb 2026
659.97K
Baseline shares
100% direct
659.97K
Direct ownership
1 position
625.41K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned659.97K
Total
659.97K direct659.97K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 659.97K | Direct |
| Total | 659.97K | 659.97K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
230.41K
Shares owned
N/A
Exercise price
9.15
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
131.66K
Shares owned
N/A
Exercise price
7.19
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
131.66K
Shares owned
N/A
Exercise price
7.25
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
131.66K
Shares owned
N/A
Exercise price
6.05
Expiration
—
Exercise window
—
Total
Underlying
625.41K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 9.15 | — | — | 230.41K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.19 | — | — | 131.66K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 7.25 | — | — | 131.66K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 6.05 | — | — | 131.66K | N/A |
| Total | 625.41K | 0.00 | ||||